Skip to content

Migraine and its management by Mundi Swarasa.

A comprehensive study on Aushadha Sevanakala (Nisha Kala) by administrastion of Mundi Swarasa on Ardhavabhedaka. - NIL

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/107266
Enrollment
30
Registered
2026-04-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

None listed

Sponsors

Dr Rashmi Prakash Swain
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having the classical signs and symptoms of Ardhavabhedaka and Migraine Patients between 16 to 60 years Patients of either sex

Exclusion criteria

Exclusion criteria: Patients age less than 16 years and more than 60 years Patients suffering from other types of headaches Patients suffering from sinusitis hypertension and fever secondary headache caused by meningitis tumour encephalitis cervical spondylitis and refractive errors Patients using other systematic drugs which may alter the results of the study

Design outcomes

Primary

MeasureTime frame
Reduction of headache after administration of nisha kala aushadhaTimepoint: 30 days

Secondary

MeasureTime frame
Mundi swarasa is effective in ardhavabhedaka Reduction in prakasha asahatwa(photophobia) Reduction in shabda asahishnuta(phonophobia) Reduction in other associated symptomsTimepoint: 30 days

Countries

India

Contacts

Public ContactProf Dr Krishna Mohanty

Govt Ayurvedic College and Hospital Balangir

krishnamohanty18@gmail.com6371321450

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026